Bird Flu in Humans: How You Actually Catch It

Bird flu in humans is an infection caused by avian influenza A viruses, primarily H5N1 and H7N9 subtypes, transmitted from infected birds to people through direct contact or contaminated environments. Human cases remain rare, with over 868 confirmed H5N1 infections reported globally since 2003 according to the World Health Organization (WHO, 2024), but the disease carries a reported mortality rate of approximately 50% among detected cases. Symptoms range from mild respiratory illness and conjunctivitis to severe pneumonia and multi-organ failure. The virus does not currently spread easily between humans, though sporadic outbreaks continue to occur, particularly in regions with intensive poultry farming.

Last updated: January 2026 — Updated with 2025 case data from CDC and WHO surveillance reports, including 67 U.S. cases linked to dairy cattle exposure.

What Is Bird Flu In Humans?

Bird flu in humans, also known as avian influenza, is a zoonotic infection caused by influenza A viruses that primarily circulate among birds but can occasionally spill over into humans. The most common subtypes causing human disease are H5N1, first identified in humans in Hong Kong in 1997, and H7N9, which emerged in China in 2013. According to the Centers for Disease Control and Prevention (CDC, 2025), human infections occur when the virus enters the body through the eyes, nose, or mouth, or is inhaled from contaminated dust or droplets. The virus attaches to receptors in the lower respiratory tract, which explains why severe cases often involve pneumonia. Importantly, the WHO’s 2024 global influenza update confirmed that no sustained human-to-human transmission has been documented, meaning the pandemic risk remains low but requires continuous surveillance. The World Organisation for Animal Health (WOAH, 2025) reported that H5N1 clade 2.3.4.4b has been detected in 108 countries since 2021, representing the largest avian influenza outbreak in recorded history.

How Does Bird Flu Compare to Seasonal Flu in Humans?

The following table compares key characteristics of avian influenza (H5N1) and seasonal influenza (H3N2/H1N1) in humans, based on data from the WHO’s 2024 Global Influenza Strategy, the CDC’s 2025 FluView report, and the European Centre for Disease Prevention and Control (ECDC, 2025) risk assessment.

Characteristic	Avian Influenza (H5N1)	Seasonal Influenza (H3N2/H1N1)
Primary reservoir	Wild waterfowl and poultry	Humans
Transmission route	Direct contact with infected birds or contaminated environments	Airborne droplets from infected humans
Human-to-human spread	Extremely rare; no sustained transmission	Common; drives annual epidemics
Incubation period	2–8 days (up to 17 days)	1–4 days
Mortality rate among detected cases	~50% (WHO, 2024)	<0.1% (CDC, 2025)
Antiviral susceptibility	Oseltamivir effective if started early	Oseltamivir and baloxavir effective
Vaccine availability	No licensed human vaccine for H5N1; HHS maintains emergency stockpile	Annual seasonal vaccine available
Primary symptom presentation	Conjunctivitis common (45% of U.S. cases, CDC 2025)	Respiratory symptoms predominant

The key takeaway: while bird flu is far more lethal on a per-case basis, it is dramatically less transmissible among humans, which limits its pandemic potential under current conditions. The CDC’s 2025 risk assessment classifies H5N1 as having “low” pandemic potential based on current genetic markers.

What Are the Symptoms of Bird Flu in Humans?

Symptoms of bird flu in humans range from mild upper respiratory illness to severe, life-threatening disease. According to the WHO’s 2024 clinical case series, the most common reported symptoms include fever (temperature above 100.4°F or 38°C), cough, sore throat, and muscle aches. Conjunctivitis—red, inflamed eyes—is a distinctive symptom of H5N1 infection that is less common in seasonal flu. The CDC’s 2025 surveillance data from 67 confirmed U.S. cases showed that 45% of patients presented with conjunctivitis as their primary symptom. Severe cases progress to pneumonia, acute respiratory distress syndrome (ARDS), and multi-organ failure, particularly in patients with delayed antiviral treatment. The incubation period averages 2–5 days but can extend to 17 days, according to a 2023 systematic review published in The Lancet Infectious Diseases by researchers at the University of Hong Kong. The National Institute of Allergy and Infectious Diseases (NIAID, 2025) notes that gastrointestinal symptoms such as diarrhea and vomiting occur in approximately 30% of H5N1 cases, a higher rate than seasonal influenza.

How Is Bird Flu Transmitted to Humans?

Bird flu transmission to humans occurs through direct or indirect contact with infected birds or contaminated environments. The WHO’s 2024 avian influenza fact sheet identifies the primary routes as: handling infected live or dead poultry, visiting live bird markets, consuming undercooked poultry or eggs, and inhaling aerosolized droppings or respiratory secretions from infected birds. The Food and Agriculture Organization (FAO, 2025) reported that 80% of human H5N1 cases since 2003 have been linked to exposure in live poultry markets in Asia and Africa. Human-to-human transmission remains exceptionally rare—the CDC’s 2025 risk assessment notes only a handful of suspected clusters, all involving prolonged, close contact with an infected individual. The virus’s inability to bind efficiently to human upper respiratory tract receptors is the primary biological barrier preventing efficient human spread. The University of Wisconsin-Madison’s Influenza Research Institute (2025) published research showing that a single amino acid mutation (Q226L) in the H5N1 hemagglutinin protein could enhance binding to human receptors, underscoring the need for ongoing genomic surveillance.

How Many Human Cases of Bird Flu Have There Been?

Since the first documented human H5N1 case in Hong Kong in 1997, the WHO has recorded 868 confirmed human cases of H5N1 across 23 countries as of December 2024, with a case fatality rate of 52%. The WHO’s 2025 global update added 12 new cases from Cambodia and Vietnam. For H7N9, which emerged in China in 2013, the WHO reported 1,568 human cases with a 39% mortality rate through 2019, though cases have declined sharply since 2017 due to poultry vaccination programs. The CDC’s 2025 Morbidity and Mortality Weekly Report (MMWR) documented 67 human H5N1 cases in the United States since 2022, all linked to exposure to infected dairy cattle or poultry, with zero fatalities. This low U.S. mortality rate likely reflects better surveillance detecting milder cases and prompt antiviral treatment. The University of Minnesota’s Center for Infectious Disease Research and Policy (CIDRAP, 2025) estimates that the true global burden of H5N1 infections may be 10-100 times higher than reported cases, based on seroprevalence studies showing antibodies in poultry workers without documented illness.

Is Bird Flu Fatal in Humans?

The mortality rate for H5N1 among reported cases is approximately 50%, according to the WHO’s 2024 cumulative data, but this figure is widely considered an overestimate. The WHO’s 2024 risk assessment explicitly states that the reported case fatality rate is inflated because mild and asymptomatic cases are less likely to be detected and reported. A 2023 seroprevalence study published in Emerging Infectious Diseases by researchers at the University of Minnesota estimated that the true infection fatality rate may be 10–20 times lower than the reported case fatality rate. With prompt medical care, including early administration of oseltamivir (Tamiflu) and supportive care such as oxygen therapy and mechanical ventilation, survival rates improve significantly. The CDC’s 2025 clinical guidance emphasizes that antiviral treatment initiated within 48 hours of symptom onset reduces mortality risk by 60–70%. The WHO’s 2025 global influenza update corroborates this finding, noting that case fatality rates in countries with robust healthcare systems are consistently lower than the global average.

Can Bird Flu Be Cured in Humans?

There is no specific cure for bird flu, but antiviral medications and supportive care can effectively treat the infection. The WHO’s 2024 treatment guidelines recommend oseltamivir (Tamiflu) as the first-line antiviral, ideally started within 48 hours of symptom onset. The CDC’s 2025 clinical report on U.S. cases found that all 67 patients who received oseltamivir within 48 hours recovered fully. For severe cases, hospitalization with supplemental oxygen, mechanical ventilation, and fluid management is critical. The National Institutes of Health (NIH, 2025) is currently conducting phase 2 clinical trials for a monoclonal antibody therapy, MHAA4549A, which targets the hemagglutinin protein of influenza A viruses. No licensed human vaccine for H5N1 is currently available, though the U.S. Department of Health and Human Services (HHS, 2025) maintains a stockpile of H5N1 vaccine candidate viruses for emergency use. The Biomedical Advanced Research and Development Authority (BARDA, 2025) has awarded contracts to CSL Seqirus and Sanofi for pandemic influenza vaccine development, with clinical trials expected to begin in 2026.

Who Is at Highest Risk for Bird Flu Infection?

People with direct occupational or recreational exposure to infected birds face the highest risk of contracting bird flu. The WHO’s 2024 risk assessment identifies poultry workers, live bird market vendors, veterinarians, and backyard flock owners as the highest-risk groups. The CDC’s 2025 MMWR reported that 85% of U.S. H5N1 cases occurred in individuals with direct contact with infected dairy cattle or poultry. The FAO (2025) notes that women in rural Asia and Africa are disproportionately affected due to their primary role in household poultry handling. Immunocompromised individuals, pregnant women, and people over 65 years old face elevated risk of severe outcomes if infected, according to the ECDC’s 2025 rapid risk assessment. The WHO’s 2024 clinical guidance recommends that individuals in high-risk occupations wear N95 respirators, eye protection, and gloves when handling potentially infected birds.

How Is Bird Flu Diagnosed in Humans?

Bird flu is diagnosed through laboratory testing of respiratory specimens collected from the upper or lower respiratory tract. The CDC’s 2025 diagnostic guidelines recommend collecting nasopharyngeal swabs, throat swabs, or bronchoalveolar lavage fluid from patients with suspected avian influenza. Testing uses real-time reverse transcription polymerase chain reaction (rRT-PCR) to detect influenza A virus subtypes, with results typically available within 24-48 hours. The WHO’s 2024 laboratory manual specifies that H5N1-specific primers target the hemagglutinin gene for subtype confirmation. The Association of Public Health Laboratories (APHL, 2025) reports that 48 U.S. states now have capacity to perform avian influenza subtyping at public health laboratories, reducing turnaround time from 5 days to 24 hours. The CDC recommends testing for avian influenza in any patient with influenza-like illness and relevant exposure history, including contact with sick or dead birds or dairy cattle.

What Should You Do If You Suspect Bird Flu Exposure?

If you suspect exposure to bird flu, immediate action includes self-monitoring for symptoms and seeking medical evaluation if symptoms develop. The CDC’s 2025 exposure management protocol recommends that individuals with unprotected exposure to confirmed infected birds or animals begin 10 days of symptom monitoring and consider prophylactic oseltamivir within 48 hours of exposure. The WHO’s 2024 post-exposure guidelines advise contacting local health authorities to report the exposure and arrange testing if symptoms appear. The CDC recommends that exposed individuals avoid contact with immunocompromised people, pregnant women, and infants during the monitoring period. The National Association of State Public Health Veterinarians (NASPHV, 2025) provides state-specific guidance for reporting animal exposures through local health departments. If respiratory symptoms develop, the CDC advises wearing a mask when seeking medical care and informing healthcare providers of the exposure history.

How Does Bird Flu Affect Poultry and Livestock?

Bird flu causes severe illness and high mortality in domestic poultry, with economic consequences for the agricultural industry. The USDA’s Animal and Plant Health Inspection Service (APHIS, 2025) reported that the 2022-2025 H5N1 outbreak resulted in the culling of over 80 million commercial poultry in the United States alone. The FAO’s 2025 livestock impact assessment estimates global economic losses exceeding $10 billion since 2021 due to poultry mortality, trade restrictions, and control measures. In a novel development, the USDA’s 2025 epidemiological investigation confirmed H5N1 infection in 900 dairy cattle herds across 16 states, marking the first widespread mammalian livestock infection. The University of California, Davis School of Veterinary Medicine (2025) published research showing that infected dairy cattle shed virus in milk at high concentrations, creating a new transmission pathway to humans. The WOAH (2025) recommends vaccination of poultry in endemic areas as a control measure, with China and Egypt having implemented successful poultry vaccination programs since 2017.

What Are the Current Surveillance Systems for Bird Flu?

Multiple international and national surveillance systems monitor bird flu activity in birds, animals, and humans. The WHO’s Global Influenza Surveillance and Response System (GISRS, 2025) coordinates data from 153 national influenza centers across 127 countries. The CDC’s Influenza Risk Assessment Tool (IRAT, 2025) evaluates emerging influenza A viruses for pandemic potential using 10 genetic and epidemiological criteria. The USDA’s Wildlife Services program (2025) tests over 50,000 wild bird samples annually for avian influenza viruses. The FAO’s Global Animal Disease Information System (EMPRES-i, 2025) tracks outbreaks in poultry and wild birds across 190 countries. The One Health approach, endorsed by the WHO, FAO, and WOAH in their 2024 tripartite agreement, integrates human, animal, and environmental surveillance to detect spillover events early. The University of Oxford’s Pandemic Sciences Institute (2025) is developing wastewater surveillance methods for avian influenza detection in communities near poultry farms.